Science AI Journal
Medicine · Research topic

Open research questions in Botulinum Toxin and Related Neurological Disorders

48 unresolved questions extracted from the limitations and future-work sections of 322 Botulinum Toxin and Related Neurological Disorders papers in our library. Each links back to the study that raised it.

What the literature leaves open

  • Detrusor sphincter dyssynergia increases the risk of inefficient voiding and further increases bladder pressures. Traditional management involves anticholinergic drugs and clean intermittent catheterization, but these have significant side effects. Surgical procedures like augmentation cystoplasty are associated with high risks of severe complications.

    Experience with Intravesical Botox in Meningomyelocele-Related Bladder Dysfunction-A Single-Center Experience · 2026 · DOI

  • Blepharospasm is a complex condition with limited treatment options. Current treatments have limitations and side effects. There is a need for a definitive method to eliminate blepharospasm.

    Long-term efficacy of neural circuit blockade for treating blepharospasm: a retrospective case series study · 2026 · DOI

  • Dysphagia and impaired orofacial motor control contribute to salivary pooling. Aspiration pneumonia is a significant concern for patients with compromised swallowing mechanisms. The evidence base regarding botulinum toxin A's specific role in preventing aspiration pneumonia is limited.

    Botulinum toxin A for sialorrhea in adults with neurological disorders: a narrative review of aspiration pneumonia risk · 2026 · DOI

  • Disordered somatosensory function in FHD. Limited understanding of the effects of Botulinum Toxin treatment on FHD. Small sample size and within-participant variability.

    Assessing the digit organisation of focal hand dystonia using 7T functional MRI · 2026 · DOI

  • Myricetin, a flavonoid with antioxidant and anti-inflammatory properties, has not been previously studied for flap survival.

    Botulinum Toxin A Versus Myricetin for Enhancing Random-Pattern Flap Survival · 2026 · DOI

  • The traditional explanation of sensory tricks as being due to peripheral sensory input is insufficient. There is a lack of understanding of the role of higher-level cognitive and attentional processes in shaping motor control in dystonia.

    Attentional or Non-Tactile Sensory Tricks in Idiopathic Cervical Dystonia: A Phenomenological Observation · 2026 · DOI

  • While placebo effects are not necessarily ruled out, the immediate and consistent benefit points in the direction of genuine physiological modulation. The process by which patients identified these non-tactile tricks was not systematically assessed, representing a limitation and an area for future investigation. Controlled neurophysiological recording at the time of non-tactile tricks would be used to further define their neural substrates and help characterize cortical circuitry mediating this effect. Specifically demonstrating task-related event-related desynchronization using EEG-EMG co-registration or fMRI-measured cortical and subcortical activity would strongly support a genuine physiological mechanism.

    Attentional or Non-Tactile Sensory Tricks in Idiopathic Cervical Dystonia: A Phenomenological Observation · 2026 · DOI

  • Further studies are needed to fully elucidate the mechanisms of BoNT/E-induced analgesia. The development of new therapies targeting the HIF-1α-NLRP3 pathway may be a promising area of research.

    Botulinum toxin type E alleviates trigeminal neuropathic pain via modulation of the HIF-1α–NLRP3 pathway · 2026 · DOI

  • The underlying mechanisms of BoNT/E-induced analgesia are not fully understood. The role of the HIF-1α-NLRP3 pathway in trigeminal neuropathic pain is not well established.

    Botulinum toxin type E alleviates trigeminal neuropathic pain via modulation of the HIF-1α–NLRP3 pathway · 2026 · DOI

  • Variability in molecular potency, receptor interactions, patient factors, and injection technique contribute to heterogeneous clinical outcomes. The need to understand how toxin-receptor binding and other factors determine clinical effect. The need to optimize reconstitution volume and injection technique to improve toxin distribution and clinical outcomes.

    Neuromodulators for Facial Aesthetics: Mechanistic Postulates and Clinical Implications · 2026 · DOI

  • The growing number of available BoNT-A formulations and advanced injection techniques necessitates a detailed understanding to optimize outcomes and minimize complications. There is a need to understand how toxin-receptor binding and other factors determine clinical effect.

    Neuromodulators for Facial Aesthetics: Mechanistic Postulates and Clinical Implications · 2026 · DOI

  • Future studies can investigate the long-term efficacy and safety of personalized combined reconstructive surgical protocols for spastic foot and ankle deformities in adult stroke patients. Research can explore the application of these protocols to other patient populations, such as those with cerebral palsy or other neurological conditions.

    Personalized combined reconstructive surgical protocols for spastic foot and ankle deformities in adult stroke: a retrospective case series · 2026 · DOI

  • The paper identifies a gap in the treatment of spastic foot and ankle deformities in adult stroke patients, highlighting the limitations of conservative treatments and the need for more effective surgical approaches. The study notes that prior work on pediatric cerebral palsy orthopedics can inform the development of personalized combined reconstructive surgical protocols for adult stroke patients.

    Personalized combined reconstructive surgical protocols for spastic foot and ankle deformities in adult stroke: a retrospective case series · 2026 · DOI

  • There is a need for further research on the long-term effects of botulinum toxin treatment. There is a need for more studies on the use of botulinum toxin in treating various strabology and neurology conditions.

    The role of botulinum toxin in the treatment of patients in strabology and neurology outpatient clinics · 2026 · DOI

  • The study had a small sample size of 10 patients. The follow-up period was limited to 6 months, which may not be sufficient to assess the long-term effectiveness of the treatment. The study did not compare the outcomes of intravesical onabotulinumtoxinA with other treatments.

    Experience with Intravesical Botox in Meningomyelocele-Related Bladder Dysfunction-A Single-Center Experience · 2026 · DOI

  • Further investigation of the belt-buckle checkpoint as a regulating mechanism for the onset of botulinum neurotoxin intoxication. Development of new methods to target the belt-buckle checkpoint for toxin neutralization. Study of the potential use of the belt-buckle checkpoint as a target for the development of fast-acting BoNTs.

    A belt-buckle checkpoint regulates the onset of botulinum neurotoxin intoxication · 2026 · DOI

  • There is a lack of targeted therapeutic strategies for blepharospasm. Current treatment options are available but no definitive method effectively eliminates blepharospasm.

    Long-term efficacy of neural circuit blockade for treating blepharospasm: a retrospective case series study · 2026 · DOI

  • The large progenitor toxin complex (L-PTC) crosses the intestinal epithelial barrier to deliver BoNT to target neurons; however, it is not clearly understood how BoNT enters the host.

    LRP1 is an entry receptor for the botulinum toxin complex in the gut · 2026 · DOI

  • The direct impact of botulinum toxin A on reducing aspiration pneumonia risk remains inadequately explored, particularly in adult populations. The evidence base regarding botulinum toxin A's specific role in preventing aspiration pneumonia is limited and has not been comprehensively explored.

    Botulinum toxin A for sialorrhea in adults with neurological disorders: a narrative review of aspiration pneumonia risk · 2026 · DOI

  • There is a need for minimally invasive, temporizing interventions that preserve airway patency and laryngeal function. Current treatment options for bilateral vocal fold immobility are limited.

    Awake transoral intralaryngeal botulinum toxin injection for early bilateral vocal fold immobility: a five-year experience · 2026 · DOI

  • There is a lack of knowledge regarding the long-term outcomes of repeated cosmetic botulinum toxin injections. There is a need to monitor subjective and objective neurological symptoms after invasive cosmetic procedures.

    АDVERSE EFFECTS AND NEUROLOGICAL DISORDERS AFTER INVASIVE COSMETOLOGY · 2026 · DOI

  • There is a lack of high-quality evidence on the efficacy and safety of botulinum toxin for bruxism and myofascial pain. The optimal dose and number of sessions are not well established.

    Toxina Botulínica para Bruxismo e Dor Miofascial · 2026 · DOI

  • The study identifies that the complexity of resistance to botulinum toxin type A is based on multiple factors including molecular structure of products, application techniques, and individual patient characteristics. It emphasizes the need for personalized therapeutic approaches and knowledge about switching between brands to maximize efficacy and safety.

    RESISTÊNCIA À TOXINA BOTULÍNICA TIPO A: COMPARAÇÃO ENTRE TRÊS MARCAS NA ESTÉTICA · 2026 · DOI

  • In the event of a functionally relevant or daily life impairing SMD or to avoid an impending complication, the medicinal treatment of a focal, multifocal and segmental increase in muscle tone with botulinum neurotoxin A (BoNT-A) is recommended; however, treatment data reveal a lack of guideline-conform treatment with BoNT‑A in Germany.

    Verbesserung der Versorgung von Patientinnen und Patienten mit spastischer Bewegungsstörung nach Schlaganfall · 2023 · DOI

  • BoNT/A is established for reducing masseter hyperactivity and may theoretically reduce abnormal somatosensory input; however, direct clinical evidence for tinnitus improvement remains insufficient.

    Masseter Muscle in Somatosensory Tinnitus and Potential Therapeutic Role for Botulinum Toxin Type A: A Scoping Review · 2026 · DOI

Most-cited papers in Botulinum Toxin and Related Neurological Disorders

Most recent work

Find a gap in your own Botulinum Toxin and Related Neurological Disorders sub-topic

This page shows what the Botulinum Toxin and Related Neurological Disorders literature already flags as unresolved. To narrow it to your specific question, run the guided finder — it searches the gap library on demand and checks candidates against 250M+ OpenAlex works.

Open the Research Gap Finder →

Related topics in Medicine

Substance Abuse Treatment and Outcomes
1,213 open questions
Artificial Intelligence in Healthcare and Education
1,153 open questions
Physical Activity and Health
718 open questions
Dementia and Cognitive Impairment Research
565 open questions
Attention Deficit Hyperactivity Disorder
544 open questions
Smoking Behavior and Cessation
532 open questions
Innovations in Medical Education
480 open questions
HIV/AIDS Research and Interventions
472 open questions
48 open questions have been extracted from the limitations and future-work passages of 322 Botulinum Toxin and Related Neurological Disorders papers in our library. Each one below links back to the study that raised it, so you can read the original claim in context.

Tools for your next paper

Gaps & Literature SearchFind open questions in any field — 120,000+ open gaps mined from our own library.Pre-CheckIs your paper ready? A Tier 1–5 acceptance probability in seconds.Journal FinderA ranked shortlist of target journals from a 17,500-venue index.Duplicate Publication CheckerCheck prior-publication & salami-slicing risk across 8 sources.Citation GeneratorFreeA DOI or title → APA, MLA, Vancouver, Chicago, BibTeX, RIS. No signup.Graphical Abstract MakerFreeTurn your findings into a colorblind-safe graphical abstract.

Compare the category — Honest roundups of the AI research tools, ours listed alongside the alternatives.

Command palette

Jump anywhere, run any action.